Literature DB >> 1403151

A quantitative autoradiographic study of the heterogeneous activity distribution of different indium-111-labeled radiopharmaceuticals in rat tissues.

B A Jönsson1, S E Strand, B S Larsson.   

Abstract

In light of the increased interest in small scale dosimetry, this paper presents a quantitative autoradiographic method for evaluation of heterogeneous activity distribution in tissues. This was studied in rat tissues after administration of 111In-chloride, -oxine, -tropolone, 111In-labeled homologous blood cells and 111In-anti-CEA-F(ab')2, using quantitative whole-body autoradiography. Quantification was performed utilizing an image analyzing system designed for whole-body autoradiographs. Very heterogeneous activity distribution was found in several tissues including the liver, spleen, kidneys, bone marrow, lymph nodes and testes. Notable was the high 111In uptake in organs characterized as rapidly proliferating, and known to have numerous transferrin receptors. In the gastrointestinal tract, all activity was associated with the intestinal walls. The heterogeneous tissue distribution shown in this investigation accentuates the necessity for performing detailed studies of the tissue distribution of radiopharmaceuticals. This is especially important for the radiation dosimetry of radionuclides emitting beta-particles or low energy electrons. We suggest whole-body autoradiography as an excellent implement to determine local activity concentrations in organs and tissues necessary for accurate absorbed dose calculations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403151

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  9 in total

1.  Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

Review 2.  Challenges and progress in predicting biological responses to incorporated radioactivity.

Authors:  R W Howell; P V S V Neti; M Pinto; B I Gerashchenko; V R Narra; E I Azzam
Journal:  Radiat Prot Dosimetry       Date:  2007-02-06       Impact factor: 0.972

3.  Lognormal distribution of cellular uptake of radioactivity: statistical analysis of alpha-particle track autoradiography.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

4.  Modeling multicellular response to nonuniform distributions of radioactivity: differences in cellular response to self-dose and cross-dose.

Authors:  Roger W Howell; Prasad V S V Neti
Journal:  Radiat Res       Date:  2005-02       Impact factor: 2.841

5.  Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.

Authors:  Roger W Howell; Didier Rajon; Wesley E Bolch
Journal:  Int J Radiat Biol       Date:  2011-11-30       Impact factor: 2.694

6.  Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy.

Authors:  R B Wilder; G L DeNardo; S Sheri; J F Fowler; B W Wessels; S J DeNardo
Journal:  Eur J Nucl Med       Date:  1996-08

7.  Induction of lethal bystander effects in human breast cancer cell cultures by DNA-incorporated Iodine-125 depends on phenotype.

Authors:  John M Akudugu; Edouard I Azzam; Roger W Howell
Journal:  Int J Radiat Biol       Date:  2012-05-16       Impact factor: 2.694

8.  Effect of emaciation and obesity on small-animal internal radiation dosimetry for positron-emitting radionuclides.

Authors:  Tianwu Xie; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-02       Impact factor: 9.236

9.  Physical Considerations for Understanding Responses of Biological Systems to Low Doses of Ionizing Radiation: Nucleosome Clutches Constitute a Heterogeneous Distribution of Target Volumes.

Authors:  Roger W Howell
Journal:  Health Phys       Date:  2016-03       Impact factor: 1.316

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.